Tchaikapharma High Quality Medicines AD (BUL:THQM)

Bulgaria · Delayed Price · Currency is BGN · Price in EUR

6.70

-0.05 (-0.74%)

At close: Jul 31, 2026

-19.14% (1Y)

Market Cap	1.30B -20.9%
Revenue (ttm)	66.61M +21.4%
Net Income	7.40M +45.2%
EPS	0.07 +46.4%
Shares Out	101.30M
PE Ratio	176.14
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	110
Open	6.75
Previous Close	6.75
Day's Range	6.70 - 6.75
52-Week Range	4.42 - 9.04
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 4, 2026

About BUL:THQM

Tchaikapharma High Quality Medicines AD develops, manufactures, and sells medicines in Bulgaria. It offers anaesthesia, anti-inflammatory and anti-rheumatic, antibiotics, cardiovascular system, digestive system, diabetes and metabolism, nervous system, over-the-counter, respiratory system, oncology, and other medicines. The company was founded in 1999 and is headquartered in Sofia, Bulgaria. Tchaikapharma High Quality Medicines AD operates as a subsidiary of Commercial League Healthcare Group Inc. [Read more]

Industry Pharmaceutical Preparations

Founded 1999

Employees 214

Stock Exchange Bulgarian Stock Exchange

Ticker Symbol THQM

Full Company Profile

Financial Performance

In 2025, BUL:THQM's revenue was 32.74 million, an increase of 20.17% compared to the previous year's 27.24 million. Earnings were 3.08 million, an increase of 33.64%.

Financial numbers in EUR Financial Statements